These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31083751)

  • 21. Understanding and preventing drug-drug and drug-gene interactions.
    Tannenbaum C; Sheehan NL
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):533-44. PubMed ID: 24745854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polypharmacy and drug-drug interactions among older and younger male prisoners in Switzerland.
    Annaheim B; Wangmo T; Bretschneider W; Handtke V; Elger BS; Belardi A; Meyer AH; Hösli R; Lutters M
    Int J Prison Health; 2019 Aug; 15(3):250-261. PubMed ID: 31329038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug-related problems in the elderly].
    Bor A; Matuz M; Doró P; Viola R; Soós G
    Orv Hetil; 2012 Dec; 153(49):1926-36. PubMed ID: 23204299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Polypharmacy viewed not only through the prism of multi-morbidity, but also as an independent geriatric syndrome].
    Weber P; Meluzínová H; Prudius D; Bielaková K
    Vnitr Lek; 2016; 62(9 Suppl 3):135-139. PubMed ID: 27734707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiovascular pharmacotherapy. Risks and adverse effects].
    Voigt N; Heijman J; Dobrev D
    Herz; 2014 Mar; 39(2):227-38; quiz 239-40. PubMed ID: 24691833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software.
    Zakrzewski-Jakubiak H; Doan J; Lamoureux P; Singh D; Turgeon J; Tannenbaum C
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):461-70. PubMed ID: 22019006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action.
    Mangin D; Bahat G; Golomb BA; Mallery LH; Moorhouse P; Onder G; Petrovic M; Garfinkel D
    Drugs Aging; 2018 Jul; 35(7):575-587. PubMed ID: 30006810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-drug Interactions in Psychiatric Practice, Part 1: Reasons, Importance, and Strategies to Avoid and Recognize Them.
    Preskorn SH
    J Psychiatr Pract; 2018 Jul; 24(4):261-268. PubMed ID: 30427809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical Performance and Quality of Life in Older Adults: Is There Any Association between Them and Potential Drug Interactions in Polymedicated Octogenarians.
    Verde Z; García de Diego L; Chicharro LM; Bandrés F; Velasco V; Mingo T; Fernández-Araque A
    Int J Environ Res Public Health; 2019 Oct; 16(21):. PubMed ID: 31671923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polypharmacy: America's other drug problem.
    Guharoy R
    Am J Health Syst Pharm; 2017 Sep; 74(17):1305-1306. PubMed ID: 28842459
    [No Abstract]   [Full Text] [Related]  

  • 32. [Polypharmacy: interaction and adverse reactions in the use of drugs by elderly people].
    Secoli SR
    Rev Bras Enferm; 2010; 63(1):136-40. PubMed ID: 20339769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using PM-TOM for the Minimization of Adverse Drug and Gene Interactions in Therapies for Common Multi-Diseases.
    Kulenovic A; Lagumdzija-Kulenovic A
    Stud Health Technol Inform; 2020 Jun; 272():205-208. PubMed ID: 32604637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of drug-drug interactions for oncology therapies: in vitro-in vivo extrapolation model-based risk assessment.
    Waters NJ
    Br J Clin Pharmacol; 2015 Jun; 79(6):946-58. PubMed ID: 25443889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug interactions in dermatological systemic treatment].
    Krause K; Jahn K; Homey B
    Hautarzt; 2021 Jan; 72(1):44-49. PubMed ID: 33242135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-drug interactions in a cohort of hospitalized elderly patients.
    Pasina L; Djade CD; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Mannucci P
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1054-60. PubMed ID: 24038765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug-drug interactions: interactions between xenobiotics].
    Haen E
    Nervenarzt; 2014 Apr; 85(4):417-26. PubMed ID: 24619146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
    Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
    BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WITH AGE COMES A guide to helping older adults avoid harmful drug effects.
    Holten J
    Diabetes Forecast; 2016 Nov; 69(6):60-63. PubMed ID: 29693917
    [No Abstract]   [Full Text] [Related]  

  • 40. Reducing polypharmacy: evidence from a simple quality improvement initiative.
    Little MO; Morley A
    J Am Med Dir Assoc; 2013 Mar; 14(3):152-6. PubMed ID: 23273343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.